Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Receivables (2019 - 2025)

Cresco Labs' Receivables history spans 7 years, with the latest figure at $37.9 million for Q4 2025.

  • For Q4 2025, Receivables fell 26.52% year-over-year to $37.9 million; the TTM value through Dec 2025 reached $37.9 million, down 26.52%, while the annual FY2025 figure was $37.9 million, 26.52% down from the prior year.
  • Receivables reached $37.9 million in Q4 2025 per CRLBF's latest filing, down from $51.6 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $59.0 million in Q4 2023 to a low of $37.9 million in Q4 2025.
  • Average Receivables over 5 years is $49.7 million, with a median of $51.6 million recorded in 2024.
  • Peak YoY movement for Receivables: soared 40.66% in 2021, then decreased 26.52% in 2025.
  • A 5-year view of Receivables shows it stood at $43.4 million in 2021, then soared by 30.23% to $56.5 million in 2022, then increased by 4.5% to $59.0 million in 2023, then dropped by 12.66% to $51.6 million in 2024, then fell by 26.52% to $37.9 million in 2025.
  • Per Business Quant, the three most recent readings for CRLBF's Receivables are $37.9 million (Q4 2025), $51.6 million (Q4 2024), and $59.0 million (Q4 2023).